Michelson diagnostics develops and markets vivosight. They are based in Kent, UK and were founded in 2006. They produce a medical scanner that is used to detect skin cancer non-melanoma. Vivo sight uses a technique known as OCT (Optical Coherence Tomography). VivoSight scanning is quick, safe, non-invasive and painless, with the need for biopsy often eliminated. Vivosight is used by physicians in Europe , the United States and Australia.